Diseases Disorders

Bringing together treatment and referral advice from existing guidelines, this text aims to improve access to services and recognition of common mental health disorders in adults and provide advice on the principles that need to be adopted to develop appropriate referral and local care pathways.

Perfect for medical and nursing students as well as for patient education, these vibrant, fully annotated charts illustrate and explain common diseases and disorders of the brain; heart; GI tract; eye and ear; endocrine, muscular, skeletal, reproductive, and respiratory systems; dental diseases; infectious diseases; healthy lifestyle issues; and cancer. Oversized, laminated pages in a convenient, spiral-bound format simplify and condense complex material in an easily accessible manner.

The Color Atlas of Diseases and Disorders of Cattle is the established and respected illustrated guide to the full range of conditions encountered in cattle worldwide. For this new edition the atlas has been redesigned to present over 840 colour illustrations and clearer than ever coverage of conditions, with a special emphasis on ease of use. The text has been updated and rewritten to encompass many new conditions including burns, 'bleeding calf syndrome', rib fracture and jejunal hemorrhagic syndrome, while treatment of existing conditions has been expanded. The emphasis of this new edition of the Color Atlas remains the visible signs of diseases and disorders in the live animal. In its third edition guise, the atlas is an indispensable reference for both experienced and novice cattle practitioners, government and industry veterinarians, as well as veterinary and agricultural students, and managers of large-scale cattle enterprises throughout the world. One hundred fresh illustrations included, improving the range of signs presented. Special emphasis on improvements in animal welfare. Extensive upgrade to chapter on locomotor disorders. Improved layout places images and relevant text closer together. Terms updated with the latest nomenclature. Inclusion of more lay terms and clarification of acronyms. One hundred fresh illustrations included, improving the range of signs presented. Special emphasis on improvements in animal welfare. Extensive upgrade to chapter on locomotor disorders. Improved layout places images and relevant text closer together. Terms updated with the latest nomenclature. Inclusion of more lay terms and clarification of acronyms.

Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders.

Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.

Clinical practice related to sleep problems and sleep disorders has been expanding rapidly in the last few years, but scientific research is not keeping pace. Sleep apnea, insomnia, and restless legs syndrome are three examples of very common disorders for which we have little biological information. This new book cuts across a variety of medical disciplines such as neurology, pulmonology, pediatrics, internal medicine, psychiatry, psychology, otolaryngology, and nursing, as well as other medical practices with an interest in the management of sleep pathology. This area of research is not limited to very young and old patientsâ€"sleep disorders reach across all ages and ethnicities. Sleep Disorders and Sleep Deprivation presents a structured analysis that explores the following: Improving awareness among the general public and health care professionals. Increasing investment in interdisciplinary somnology and sleep medicine research training and mentoring activities. Validating and developing new and existing technologies for diagnosis and treatment. This book will be of interest to those looking to learn more about the enormous public health burden of sleep disorders and sleep deprivation and the strikingly limited capacity of the health care enterprise to identify and treat the majority of individuals suffering from sleep problems.

By far the majority of women presenting with a breast complaint will be diagnosed as having a benign rather than malignant condition. Despite this, clinical and research interest has always favoured breast cancer, and few publications have attempted to cover benign breast disorders as an independent entity focusing instead on benign breast disease in relation to breast cancer and none provide the complete and pragmatic coverage found in this text.Hughes, Mansel and Webster's Benign Disorders and Diseases of the Breast represents the distillation of over 35 years of clinical experience and research in the Cardiff Clinic and is unique in its depth of coverage of the entire spectrum of benign breast complaints. The third edition of this critically acclaimed book provides practical and detailed management guidelines. Relevant investigations are discussed and clear advice is given for the most effective treatment strategies in each condition, including dealing with treatment failures and recurring problems. The underlying pathology and physiology are also discussed from the clinician's viewpoint to help understand clinical presentations and response to treatment.

This book provides a cutting-edge review of polyglutamine disorders. It primarily focuses on two main aspects: (1) the mechanisms underlying the pathologies’ development and progression, and (2) the therapeutic strategies that are currently being explored to stop or delay disease progression. Polyglutamine (polyQ) disorders are a group of inherited neurodegenerative diseases with a fatal outcome that are caused by an abnormal expansion of a coding trinucleotide repeat (CAG), which is then translated in an abnormal protein with an elongated glutamine tract (Q). To date, nine polyQ disorders have been identified and described: dentatorubral-pallidoluysian atrophy (DRPLA); Huntington’s disease (HD); spinal–bulbar muscular atrophy (SBMA); and six spinocerebellar ataxias (SCA 1, 2, 3, 6, 7, and 17). The genetic basis of polyQ disorders is well established and described, and despite important advances that have opened up the possibility of generating genetic models of the disease, the mechanisms that cause neuronal degeneration are still largely unknown and there is currently no treatment available for these disorders. Further, it is believed that the different polyQ may share some mechanisms and pathways contributing to neurodegeneration and disease progression.